Quality and consistency of clinical practice guidelines on the prevention of food allergy and atopic dermatitis: Systematic review protocol.

AD, Atopic dermatitis AGREE-II, Appraisal of Guidelines for Research and Evaluation - II AGREE-REX, Appraisal of Guidelines for Research and Evaluation–Recommendations Excellence (AGREE-REX) Atopic dermatitis CPG, Clinical Practice Guideline Clinical practice guideline Eczema FA, Food allergy Food allergy ISAAC, International Study of Asthma and Allergies in Childhood LEAP, Learning Early About Peanut Allergy PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses PROSPERO, Prospective Register of Systematic Reviews Primary prevention SR, Systematic review WAO, World Allergy Organization

Journal

The World Allergy Organization journal
ISSN: 1939-4551
Titre abrégé: World Allergy Organ J
Pays: United States
ID NLM: 101481283

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 28 03 2022
revised: 03 07 2022
accepted: 21 07 2022
pubmed: 4 10 2022
medline: 4 10 2022
entrez: 3 10 2022
Statut: epublish

Résumé

Allergy prevention strategies have gained significant traction as a means to attenuate the growing burden of allergic diseases over the past decade. As the evidence base for primary prevention of food allergy (FA) and atopic dermatitis (AD) is constantly advancing, clinical practice guideline (CPG) recommendations on interventions for FA and AD prevention vary in quality and consistency among professional organizations. We present a protocol for a systematic review of CPGs on primary prevention of FA and AD. We will systematically review and appraise all CPGs addressing primary prevention of FA and AD and report our findings according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Electronic databases and manual website searches from January 2011 to March 2021 without language or geographical restrictions, and supplemented by author contact, will generate the list of potentially relevant CPGs to screen. Evaluation of the methodological quality, consistency, and global applicability of shortlisted CPGs will be performed by members of the Allergy Prevention Work Group of the World Allergy Organization (WAO) using the Appraisal of Guidelines for Research and Evaluation (AGREE) II and AGREE-REX (Recommendations EXcellence). instruments. Guideline contents, consistency, and quality of the recommendations will be summarised in tabular and narrative formats. We aim to present consolidated recommendations from international guidelines of the highest methodological quality and applicability, as determined by AGREE II and AGREE-REX. This systematic review will provide a succinct overview of the quality and consistency of recommendations across all existing CPGs for FA and AD prevention, as well as crucial perspectives on applicability of individual recommendations in different geographical contexts. Results from this systematic review will be reported in a peer-reviewed journal. It will also inform a position statement by WAO to provide a practical framework to guide the development of future guidelines for allergy prevention worldwide. CRD42021265689.

Sections du résumé

Background and aims UNASSIGNED
Allergy prevention strategies have gained significant traction as a means to attenuate the growing burden of allergic diseases over the past decade. As the evidence base for primary prevention of food allergy (FA) and atopic dermatitis (AD) is constantly advancing, clinical practice guideline (CPG) recommendations on interventions for FA and AD prevention vary in quality and consistency among professional organizations. We present a protocol for a systematic review of CPGs on primary prevention of FA and AD.
Methods UNASSIGNED
We will systematically review and appraise all CPGs addressing primary prevention of FA and AD and report our findings according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Electronic databases and manual website searches from January 2011 to March 2021 without language or geographical restrictions, and supplemented by author contact, will generate the list of potentially relevant CPGs to screen. Evaluation of the methodological quality, consistency, and global applicability of shortlisted CPGs will be performed by members of the Allergy Prevention Work Group of the World Allergy Organization (WAO) using the Appraisal of Guidelines for Research and Evaluation (AGREE) II and AGREE-REX (Recommendations EXcellence). instruments. Guideline contents, consistency, and quality of the recommendations will be summarised in tabular and narrative formats. We aim to present consolidated recommendations from international guidelines of the highest methodological quality and applicability, as determined by AGREE II and AGREE-REX.
Dissemination UNASSIGNED
This systematic review will provide a succinct overview of the quality and consistency of recommendations across all existing CPGs for FA and AD prevention, as well as crucial perspectives on applicability of individual recommendations in different geographical contexts. Results from this systematic review will be reported in a peer-reviewed journal. It will also inform a position statement by WAO to provide a practical framework to guide the development of future guidelines for allergy prevention worldwide.
Prospero registration number UNASSIGNED
CRD42021265689.

Identifiants

DOI: 10.1016/j.waojou.2022.100679 PMID: 36185546 PMC: PMC9478906
pubmed: 36185546
doi: 10.1016/j.waojou.2022.100679
pii: S1939-4551(22)00055-2
pmc: PMC9478906
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100679

Informations de copyright

© 2022 The Author(s).

Auteurs

Agnes Sze Yin Leung (AS)

Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Elizabeth Huiwen Tham (EH)

Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore.

Miny Samuel (M)

Research Support Unit, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore.

Daniel Munblit (D)

Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom.

Derek K Chu (DK)

Departments of Medicine and Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, L8S 4L8, Canada.

Lamia Dahdah (L)

Translational Research in Pediatric Specialities Area, Division of Allergy, Bambino Gesù Children's Hospital, Rome, Italy.

Kiwako Yamamoto-Hanada (K)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Thulja Trikamjee (T)

Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.

Vijay Warad (V)

Sai Allergy Asthma Eye Hospital, Pune, India.

Andre van Niekerk (A)

Department of Paediatrics and Child Health, School of Medicine, University of Pretoria, South Africa.

Santiago Martinez (S)

Florida State University College of Medicine, Tallahassee, FL, USA.

Anne Ellis (A)

Department of Medicine, Queen's University, and the Division of Allergy and Immunology, Kingston General Hospital, Kingston, ON, Canada.

Leonard Bielory (L)

Department of Medicine, Allergy, Immunology and Ophthalmology, Hackensack Meridian School of Medicine, Springfield, NJ, USA.
Center for Environmental Prediction Rutgers University, New Brunswick, NJ, USA.
Kean University, Center for Aerobiology Research, New Jersey Center for Science, Technology and Mathematics, Union, NJ, USA.

Gustavo Cuadros (G)

District Department of Health of Bogota, Bogota, Colombia.

Hugo van Bever (H)

Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, Singapore.

Dana Wallace (D)

Nova Southeastern Allopathic Medical School, Fort Lauderdale, FL, USA.

Mimi Tang (M)

Allergy Immunology, Murdoch Children's Research Institute, Melbourne, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Australia.
Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia.

James Sublett (J)

Pediatric Allergy & Immunology, University of Louisville School of Medicine, Louisville, KY, USA.

Gary Wing Kin Wong (GWK)

Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Classifications MeSH